Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: Possible implications in iron overload

Circulation Research

Volumn 84, Issue 11, 1999, Pages 1302-1309

  Tsushima, Robert G ^a   Wickenden, Alan D ^a   Bouchard, Ron A ^a   Oudit, Gavin Y ^a   Liu, Peter P ^a   Backx, Peter H ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Ca2+; Channels; Heart failure; Iron overload; Permeability

Indexed keywords

CALCIUM CHANNEL; IRON;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CHANNEL GATING; HEART FAILURE; HEART MUSCLE CELL; IRON OVERLOAD; IRON TRANSPORT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TISSUE LEVEL;

EID: 0033546223     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.11.1302     Document Type: Article

References (63)

1. Halliwell B, Gutteridge MC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biohem J. 1984;219:1-14.
2. Tenenbein M, Kopelow ML, deSa DJ. Myocardial failure and shock in iron poisoning. Hum Toxicol. 1988;7:281-284.
3. Anderson AC. Iron poisoning in children. Curr Opin Pediatr. 1994;6: 289-294.
4. Bannerman RM, Keusch G, Kreimer-Birnbaum M, Vance VK, Vaughan S. Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria. Am J Med. 1967;42: 476-486.
5. Schafer AI, Cheron RG, Dluhy R, Cooper B, Gleason RE, Soeldner JS, Bunn HF. Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med. 1981;304:319-324.
6. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med. 1994;331:567-573.
7. Liu P, Olivieri N. Iron overload cardiomyopathies: new insights into an old disease. Cardiovasc Drugs Ther. 1994;8:101-110.
8. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
9. Bothwell TH, MacPhail AP. Hereditary hemochromatosis: ethiologic, pathologic, and clinical aspects. Semin Hematol. 1998;35:55-71.
10. Craig JE, Rochette J, Fisher CA, Weatherall DJ, Marc S, Lathrop GM, Demenais F, Thein S. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach. Nat Genet. 1996;12:58-64.
11. Bottomley SS. Secondary iron overload disorders. Semin Hematol. 1998; 35:77-86.
12. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Lui PP, McGee A, Martin M, Koren G, Cohen AR. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med. 1994;331:574-578.
13. Wolfe L, Olivieri N, Sallan D, Colan S, Vera R, Propper R, Freedman MH, Nathan DG. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med. 1985;312: 1600-1603.
14. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739-761.
15. Olivieri NF, Brittenham GM, McLaren CE, Templeton DM, Cameron RG, McClelland RA, Burt AD, Fleming KA. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med. 1998;339:417-423.
16. De Silva DM, Askwith CC, Kaplan J. Molecular mechanisms of iron uptake in eukaryotes. Physiol Rev. 1994;76:31-47.
17. Koeller DM, Horowitz JA, Casey JL, Klausner RD, Harford JB. Translation and the stability of mRNAs encoding the transferrin receptor and c-fos. Proc Natl Acad Sci U S A. 1991;88:7778-7782.
18. Link G, Pinson A, Hershko C. Heart cells in culture: a model of myocardial iron overload and chelation. J Lab Clin Med. 1985;106:147-153.
19. Parkes JG, Hussain RA, Olivieri NF, Templeton DM. Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells. J Lab Clin Med. 1993;122:36-47.
20. Kaplan J, Jordan I, Sturrock A. Regulation of the transferrin-independent iron transport system in cultured cells. J Biol Chem. 1991;266: 2997-3004.
21. Randell EW, Parkes JG, Olivieri NF, Templeton DM. Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular iron. J Biol Chem. 1994;269:16046-16053.
22. + channel gene expression rat ventricle. J Physiol (Lond). 1997;504:271-286.
23. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100.
24. Sanguinetti MC, Kass RS. Photoalteration of calcium channel blockade in the cardiac Purkinje fiber. Biophys J. 1984;45:873-880.
25. 3+ transport by iron-loaded cardiac myocytes. Toxicology. 1997;117: 141-151.
26. Hershko C, Graham G, Bates GW, Rachmilewitz EA. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol. 1978;40:255-263.
27. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis: characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem. 1989;264:4417-4422.
28. Al-Refaie FN, Wickens DG, Wonke B, Kontoghiorghes GF, Hoffbrand AV. Serum non-transferrin-bound iron in beta-thalassemia major patients treated with desferrioxamine and L1. Br J Haematol. 1992;82:431-436.
29. Cheney K, Gumbiner C, Benson B, Tenenbein M. Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine. J Toxicol Clin Toxicol. 1995;33:61-66.
30. Winegar BD, Kelly R, Lansman JB. Block of current through single calcium channels by Fe, Co, and Ni: location of the transition metal binding site in the pore. J Gen Physiol. 1991;97:351-367.
31. Hille B. Selective permeability: independence. In: Hille B, ed. Ionic Channels of Excitable Membranes. 2nd ed. Sunderland, Mass: Sinauer; 1992: 337-361.
32. Hess P, Lansman JB, Tsien RW. Calcium channel selectivity for divalent and monovalent cations: voltage and concentration dependence of single channel current in ventricular heart cells. J Gen Physiol. 1986;88: 293-319.
33. Atar D, Backx PH, Appel MM, Gao WD, Marban E. Excitation-transcription coupling mediated by zinc influx through voltage-dependent calcium channels. J Biol Chem. 1995:270:2473-2477.
34. 2+: voltage and concentration dependence of calcium entry into the pore. J Gen Physiol. 1987;88: 321-347.
35. Hess P, Lansman JB, Tsien RW. Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists. Nature. 1984;311:538-544.
36. Sanguinetti MC, Krafte DS, Kass RS. Voltage-dependent modulation of Ca channel current in heart cells by Bay K 8644. J Gen Physiol. 1986; 88:369-392.
37. Bean BP, Nowycky MC, Tsien RW. β-Adrenergic modulation of calcium channels in frog ventricular heart cells. Nature. 1984;307:371-375.
38. Yue DT, Herzig S, Marban E. β-Adrenergic stimulation of calcium channels occur by potentiation of high-activity gating modes. Proc Natl Acad Sci U S A. 1990;87:753-757.
39. Sturrock A, Alexander J, Lamb J, Craven CM, Kaplan J. Characterization of a transferrin-independent uptake system for iron in HeLa cells. J Biol Chem. 1990;265:3139-3145.
40. Frankenhauser B, Hodgkin AL. The action of calcium on the electrical properties of squid axons. J Physiol (Lond). 1957:137:218-244.
41. Byerly L, Chase PB, Stimers JR. Permeation and interaction of divalent cations in calcium channels of snail neurons. J Gen Physiol. 1985;85: 491-518.
42. Akaike N, Nishi K, Oyama Y. Characteristics of manganese current and its comparison with currents carried by other divalent cations in snail soma membranes. J Membrane Biol. 1983;76:289-297.
43. Aimers W, McCleskey EW. Non-selective conductance in calcium channels in frog muscle: calcium selectivity in a single-file pore. J Physiol (Lond). 1984;353:585-608.
44. Hess P, Tsien RW. Mechanism of ion permeation through calcium channels. Nature. 1984;309:453-456.
45. 2+ channels. Neuron. 1994;12:1301-1313.
46. 2+ channels. Science. 1995;270:1502-1506.
47. Yatani A, Brown AM. The calcium channel blocker nitrendipine blocks sodium channels in neonatal rat cardiac myocytes. Circ Res. 1985;56: 868-875.
48. Avdonin V, Shibata EF, Hoshi T. Dihydropyridine action on voltage-dependent potassium channels expressed in Xenopus oocytes. J Gen Physiol. 1997;109:169-180.
49. Zhang X, Anderson JW, Fedida D. Characterization of nifedipine block of the human heart delayed rectifier, hKvl.5. J Pharmacol Exp Ther. 1997; 281:1247-1256.
50. Sanguinetti MC, Kass RS. Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res. 1984;55:336-348.
51. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, Nussberger S, Gollan JL, Hediger MA. Cloning and characterization a mammalian proton-coupled metal-ion transporter. Nature. 1997;388: 482-488.
52. 2+ currents from newborn rat cardiomyocytes in primary culture. Pflugers Arch. 1994;428:241-249.
53. Tsien RW, Hess P, McCleskey EW, Rosenberg RL. Calcium channels: mechanisms of selectivity, permeation, and block. Annu Rev Biophys Biophys Chem. 1987;16:265-290.
54. Bouchard RA, Clark RB, Giles WR. Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes: action potential voltage-clamp measurements. Circ Res. 1995;76:790-801.
55. Jacobs A. Low molecular weight intracellular iron transport compounds. Blood. 1977;50:433-439.
56. Hershko C, Link G, Pinson A. Modification of iron uptake and lipid peroxidation by hypoxia, ascorbic acid, and α-tocopherol in iron-loaded rat myocardial cell cultures. J Lab Clin Med. 1987;110:355-361.
57. Buja LM, Roberts WC. Iron in the heart: etiology and clinical significance. Am J Med. 1971;51:209-221.
58. 2+ channels. Neuron. 1992;9:197-207.
59. Guerra L, Cerbai E, Gessi S, Borea PA, Mugelli A. The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes. Br J Pharmacol. 1996;118:1278-1284.
60. + channels. Circ Res. 1995;76:325-334.
61. 2+ transients and contraction. J Physiol (Lond). 1991;434:283-312.
62. Armstrong CM, Matteson DR. Two distinct populations of calcium channels in a clonal line of pituitary cells. Science. 1985;227:65-67.
63. Plant TD. Properties and calcium-dependent inactivation of calcium currents in cultured mouse pancreatic β-cells. J Physiol (Lond). 1988; 404:731-747.